Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Steinman

Showing results (81-90 of 335) with videos related to

Pageof 34
Sort By:
JAMA Neurology|March 6, 2013
The gender gap in multiple sclerosis: intersection of science and societyShannon E Dunn, Lawrence Steinman
Immunity|May 17, 2008
Type 1 interferons cool the inflamed brainRobert C Axtell, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal LeukoencephalopathyNavid Manouchehri, Lawrence Steinman, Olaf Stuve
Current Opinion in Neurology|May 17, 2006
Emerging therapeutic targets in multiple sclerosisPaulo Fontoura, Lawrence Steinman, Ariel Miller
The Journal of Experimental Medicine|January 18, 2023
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger diseaseLawrence Steinman, Roberto Patarca, William Haseltine
International Reviews of Immunology|December 2, 2005
Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptidesPaulo Fontoura, Hideki Garren, Lawrence Steinman
Nature Reviews. Immunology|April 28, 2006
Statin therapy and autoimmune disease: from protein prenylation to immunomodulationJohn Greenwood, Lawrence Steinman, Scott S Zamvil
Current Protocols in Immunology|April 25, 2008
Evaluating human T cell receptor gene expression by PCREmanuela Gussoni, Michael A Panzara, Lawrence Steinman
Trends in Immunology|May 3, 2011
Interferon-β exacerbates Th17-mediated inflammatory diseaseRobert C Axtell, Chander Raman, Lawrence Steinman
Clinical Reviews in Allergy & Immunology|January 11, 2012
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityRobert C Axtell, Chander Raman, Lawrence Steinman
Pageof 34

Showing results (81-90 of 335) with videos related to

Sort By:
Pageof 34
JAMA Neurology|March 6, 2013
The gender gap in multiple sclerosis: intersection of science and societyShannon E Dunn, Lawrence Steinman
Immunity|May 17, 2008
Type 1 interferons cool the inflamed brainRobert C Axtell, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal LeukoencephalopathyNavid Manouchehri, Lawrence Steinman, Olaf Stuve
Current Opinion in Neurology|May 17, 2006
Emerging therapeutic targets in multiple sclerosisPaulo Fontoura, Lawrence Steinman, Ariel Miller
The Journal of Experimental Medicine|January 18, 2023
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger diseaseLawrence Steinman, Roberto Patarca, William Haseltine
International Reviews of Immunology|December 2, 2005
Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptidesPaulo Fontoura, Hideki Garren, Lawrence Steinman
Nature Reviews. Immunology|April 28, 2006
Statin therapy and autoimmune disease: from protein prenylation to immunomodulationJohn Greenwood, Lawrence Steinman, Scott S Zamvil
Current Protocols in Immunology|April 25, 2008
Evaluating human T cell receptor gene expression by PCREmanuela Gussoni, Michael A Panzara, Lawrence Steinman
Trends in Immunology|May 3, 2011
Interferon-β exacerbates Th17-mediated inflammatory diseaseRobert C Axtell, Chander Raman, Lawrence Steinman
Clinical Reviews in Allergy & Immunology|January 11, 2012
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityRobert C Axtell, Chander Raman, Lawrence Steinman
Pageof 34